Endocrine Today Current Issue
The following articles appeared in the print edition of Endocrine Today.
Table of Contents
- Thyroid eye disease requires joint management with ophthalmologists Michael Monostra; Alex Young
-
- Connectivity, digital tools becoming the ‘sixth vital sign’ in health care Michael Monostra
- Convey mindfulness, realistic expectations for ‘diabetes perfectionists’ Jill Rollet
- Embrace diabetes apps as part of technology-enabled practice Regina Schaffer
- Extra support may alleviate widespread disparities in diabetes technology adoption Regina Schaffer
- FDA approves first interchangeable biosimilar insulin Regina Schaffer
- Few high-quality studies published on dietary supplements, therapies for weight loss Michael Monostra
- New diabetes technology expected to improve customization, availability of real-time data Michael Monostra
- Prevent diabetes misdiagnosis, mismanagement through precision medicine Regina Schaffer
-
- Regular antidepressant use may lower risk for advanced diabetes complications Regina Schaffer
- SURPASS data: ‘Impressive’ tirzepatide could change goals for diabetes treatment Regina Schaffer
- Testosterone therapy may be safe for use in men with advanced prostate cancer Michael Monostra
- VIDEO: Implications of SOLOIST, SCORED trials for heart failure treatment in diabetes Richard E. Pratley, MD
- FDA approves faster-acting insulin lispro for pump therapy
- FDA approves once-weekly exenatide for children with type 2 diabetes Regina Schaffer
- New drug therapy will change the CKD landscape Lance Sloan, MD, MSE, FACE, FASN, FACP, FASPC, FEAA
- Should teprotumumab become first-line therapy for thyroid eye disease?
-